Protection studies with recombinant excretory/secretory proteins of Haemonchus contortus. 2002

L Vervelde, and M A W Van Leeuwen, and M Kruidenier, and F N J Kooyman, and J F Huntley, and I Van Die, and A W C A Cornelissen
Utrecht University, Faculty Veterinary Medicine, Department of Infectious Diseases and Immunology, Division of Parasitology and Tropical Veterinary Medicine, Utrecht, The Netherlands. l.vervelde@vet.uu.nl

The efficacy of two recombinant proteins of Haemonchus contortus was studied in both adult sheep and young lambs. These 15 and 24 kDa excretory/secretory proteins were given combined, either supplemented or not with a glycan-rich insect cell extract. In 9-month-old sheep (trial 1), faecal egg output and worm burden were reduced by 49% and 55%, respectively, after vaccination with rec15/24, and by 46% and 65% after vaccination with rec15/24 and glycan extract. No reduction in egg output or number of worms was found in young lambs using the above recombinant proteins plus glycan-rich extract (trial 2). When trial 1 was repeated (trial 3), the protection could not be reproduced, possibly due to differences in batches of recombinant proteins. In all sheep, independent of their age, rec15/24-specific immunoglobulin (Ig)G1 and IgA titres were present, but 9-month-old protected sheep had significantly higher IgA titres than the lambs. Addition of glycans resulted in lower rec15/24-specific IgG1 and IgA in 9-month-old sheep after challenge. This did not affect the level of protection. A significant negative correlation was found between IgA and worm numbers in protected sheep immunized with rec15/24 supplemented with glycans. Total IgE and rec15/24 specific IgE titres were low. The number of eosinophils, mast cells, sheep mast cell protease (SMCP)+ cells and IgA+ cells did not differ between the protected and unprotected sheep, but the lambs had significantly fewer mast cells independent of their immunization.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006189 Haemonchus A genus of parasitic nematode worms which infest the duodenum and stomach of domestic and wild herbivores, which ingest it with the grasses (POACEAE) they eat. Infestation of man is accidental. Hemonchus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000947 Antigens, Helminth Any part or derivative of a helminth that elicits an immune reaction. The most commonly seen helminth antigens are those of the schistosomes. Helminth Antigens
D012756 Sheep Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS. Ovis,Sheep, Dall,Dall Sheep,Ovis dalli

Related Publications

L Vervelde, and M A W Van Leeuwen, and M Kruidenier, and F N J Kooyman, and J F Huntley, and I Van Die, and A W C A Cornelissen
January 2021, Veterinary research,
L Vervelde, and M A W Van Leeuwen, and M Kruidenier, and F N J Kooyman, and J F Huntley, and I Van Die, and A W C A Cornelissen
October 1997, Parasite immunology,
L Vervelde, and M A W Van Leeuwen, and M Kruidenier, and F N J Kooyman, and J F Huntley, and I Van Die, and A W C A Cornelissen
January 2012, Veterinary research forum : an international quarterly journal,
L Vervelde, and M A W Van Leeuwen, and M Kruidenier, and F N J Kooyman, and J F Huntley, and I Van Die, and A W C A Cornelissen
September 1997, Molecular and biochemical parasitology,
L Vervelde, and M A W Van Leeuwen, and M Kruidenier, and F N J Kooyman, and J F Huntley, and I Van Die, and A W C A Cornelissen
January 2023, Computational and structural biotechnology journal,
L Vervelde, and M A W Van Leeuwen, and M Kruidenier, and F N J Kooyman, and J F Huntley, and I Van Die, and A W C A Cornelissen
November 1998, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B,
L Vervelde, and M A W Van Leeuwen, and M Kruidenier, and F N J Kooyman, and J F Huntley, and I Van Die, and A W C A Cornelissen
June 2016, Oncotarget,
L Vervelde, and M A W Van Leeuwen, and M Kruidenier, and F N J Kooyman, and J F Huntley, and I Van Die, and A W C A Cornelissen
December 2022, Parasite immunology,
L Vervelde, and M A W Van Leeuwen, and M Kruidenier, and F N J Kooyman, and J F Huntley, and I Van Die, and A W C A Cornelissen
May 2020, Veterinary research,
L Vervelde, and M A W Van Leeuwen, and M Kruidenier, and F N J Kooyman, and J F Huntley, and I Van Die, and A W C A Cornelissen
July 2005, Parasitology research,
Copied contents to your clipboard!